Epilepsy, Idiopathic Generalized
Also known as: Idiopathic Generalized Epilepsy / Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus / Generalized idiopathic epilepsy and epileptic syndromes / Idiopathic generalized epilepsy (disorder) / Idiopathic generalised epilepsy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01202 | Levetiracetam | A novel anticonvulsant agent used as an adjunct medication to manage partial onset, myoclonic, and generalized tonic-clonic seizures in patients with epilepsy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01202 | Levetiracetam | Synaptic vesicle glycoprotein 2A | target |
| DB01202 | Levetiracetam | P-glycoprotein 1 | transporter |
| DB01202 | Levetiracetam | Voltage-dependent N-type calcium channel subunit alpha-1B | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01202 | Levetiracetam | 4 | Completed | 1 |
| DB00313 | Valproic acid | 4 | Completed | 1 |
| DB08883 | Perampanel | Not Available | Completed | 1 |